These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14707063)

  • 1. An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes.
    Hartemann-Heurtier A; Mars LT; Bercovici N; Desbois S; Cambouris C; Piaggio E; Zappulla J; Saoudi A; Liblau RS
    J Immunol; 2004 Jan; 172(2):915-22. PubMed ID: 14707063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage.
    Bercovici N; Heurtier A; Vizler C; Pardigon N; Cambouris C; Desreumaux P; Liblau R
    J Immunol; 2000 Jul; 165(1):202-10. PubMed ID: 10861053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts.
    Vizler C; Bercovici N; Heurtier A; Pardigon N; Goude K; Bailly K; Combadière C; Liblau RS
    J Immunol; 2000 Dec; 165(11):6314-21. PubMed ID: 11086068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells.
    Griseri T; Beaudoin L; Novak J; Mars LT; Lepault F; Liblau R; Lehuen A
    J Immunol; 2005 Aug; 175(4):2091-101. PubMed ID: 16081775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective CD8+ T cell peripheral tolerance in nonobese diabetic mice.
    Kreuwel HT; Biggs JA; Pilip IM; Pamer EG; Lo D; Sherman LA
    J Immunol; 2001 Jul; 167(2):1112-7. PubMed ID: 11441123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
    Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
    J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells.
    Morgan DJ; Nugent CT; Raveney BJ; Sherman LA
    J Immunol; 2004 Jan; 172(2):1000-8. PubMed ID: 14707073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
    Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
    J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
    Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
    Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas.
    Nugent CT; Morgan DJ; Biggs JA; Ko A; Pilip IM; Pamer EG; Sherman LA
    J Immunol; 2000 Jan; 164(1):191-200. PubMed ID: 10605011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
    Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
    J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens.
    Morgan DJ; Kreuwel HT; Sherman LA
    J Immunol; 1999 Jul; 163(2):723-7. PubMed ID: 10395663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel model of double transgenic mouse results in autoimmune diabetes in males.
    Chabot S; Alvarez F; Amrani A; Djilali-Saiah I
    Autoimmunity; 2016 Sep; 49(6):397-404. PubMed ID: 27683954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide.
    Alleva DG; Gaur A; Jin L; Wegmann D; Gottlieb PA; Pahuja A; Johnson EB; Motheral T; Putnam A; Crowe PD; Ling N; Boehme SA; Conlon PJ
    Diabetes; 2002 Jul; 51(7):2126-34. PubMed ID: 12086942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
    Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
    J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
    Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
    J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.